With February being National Cancer Prevention Month, here are the latest updates in cancer prevention.
The FDA granted a priority review to Deciphera Pharmaceuticals’ new drug application for ripretinib to treat patients with advanced gastrointestinal stromal tumors.
The chief of surgical oncology at the UK Markey Cancer Center discussed liquid biopsies and their potential importance for diagnosing gastric cancer.
The professor from MD Anderson Cancer Center spoke about the exploration of different concepts for the treatment of gastrointestinal cancers.
The expert spoke about ongoing trials of novel treatment strategies that may lead to the development of new therapies in this space.
This technology identified a practical method for detecting multiple gastrointestinal cancers from a single noninvasive blood test.
Incidence of early-onset gastric cancer has steadily increased in the US, now comprising >30% of new gastric cancer cases today, causing researchers to try and discover what makes this disease type unique.
Researchers indicated the importance in improving access to and uptake of CRC screening in these underserved populations.
Although researchers determined which regimen was preferred among physicians in treating metastatic colorectal cancer, they found that shared decision-making should include observation as an acceptable option.
Researchers assessed whether ctDNA could accurately differentiate metastases during the neoadjuvant period after surgery to guide therapy adaptation.